COPENHAGEN Minipuberty Study
NCT02784184 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 280
Last updated 2019-02-15
Summary
Minipuberty is a term used to describe the transient activation of the pituitary-gonadal axis 2-3 months after birth in both boys and girls. It is, however, not known why infants reach adult levels of reproductive hormones in early life, nor is the exact timing of the peak known. Furthermore, what determines the timing of peaks and suppressions of reproductive hormones from infancy throughout childhood and into adolescence remains to be elucidated.
The study aims to described and evaluate dynamic changes in the hypothalamic-pituitary- gonadal axis in early postnatal life.
Conditions
- Child Development
- Disorders of Sex Development
Sponsors & Collaborators
-
Rigshospitalet, Denmark
lead OTHER
Principal Investigators
-
Anders Juul, Prof. · Rigshospitalet, Denmark
-
Alexander S Busch, MD · Rigshospitalet, Denmark
Eligibility
- Max Age
- 12 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-08-31
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
Countries
- Denmark
Study Locations
More Related Trials
-
Kisspeptin in the Evaluation of Delayed Puberty
NCT01438034 ·Status: COMPLETED ·Phase: PHASE1
-
Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi Syndrome
NCT00705172 ·Status: COMPLETED
-
Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone
NCT01327924 ·Status: COMPLETED
-
Long-term Outcome of GnRH Analogues Treatment of Children With Idiopathic Central Precocious Puberty
NCT02790112 ·Status: UNKNOWN ·Phase: NA
-
Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardation
NCT01697644 ·Status: COMPLETED ·Phase: PHASE4
-
Biological Age in Children With GH Deficiency Undergoing Hormone Replacement Therapy
NCT06294860 ·Status: COMPLETED
-
Study of Growth-promoting and Metabolic Effects of Growth Hormone (rhGH)
NCT00597480 ·Status: TERMINATED ·Phase: PHASE4
-
Growth Hormone Treatment of Children Born With Retarded Intrauterine Growth at Age 2-5 Years
NCT00184691 ·Status: COMPLETED ·Phase: PHASE3
-
Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children
NCT00438217 ·Status: UNKNOWN ·Phase: PHASE4
-
Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment of Satisfaction
NCT00519844 ·Status: COMPLETED ·Phase: PHASE4
-
Long Term Metabolic Safety of Norditropin® Treatment of Small for Gestational Age (SGA) Subjects
NCT00787878 ·Status: COMPLETED
-
Retrospective Study Of The Influence Of Age At Start Of Growth Hormone Treatment On Height Gain In Children Born Small for Gestational Age
NCT01897753 ·Status: COMPLETED
-
An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)
NCT01009905 ·Status: COMPLETED
-
Individualizing Dose of Growth Hormone to Maintain Normal Growth Velocity After Fulfilled Catch up Growth in Children
NCT02879747 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
NCT03972345 ·Status: ENROLLING_BY_INVITATION
-
Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment in Adults With Prader-Willi Syndrome
NCT00372125 ·Status: COMPLETED ·Phase: NA
-
Follow-up to Adult Height of a Cohort of Subjects Born Small for the Gestational Age and Treated With Growth Hormone
NCT01196156 ·Status: COMPLETED
-
Somatropin Therapy In Children Born Preterm But Appropriate For Gestational Age
NCT00174460 ·Status: COMPLETED ·Phase: PHASE2
-
Hypogonadotrophic Hypogonadism in Genetic Neurodevelopmental Conditions
NCT07049042 ·Status: RECRUITING
-
Pharmacodynamics of CNP During Growth Hormone Treatment
NCT01504802 ·Status: COMPLETED
-
Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age
NCT00557336 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Prospective Study on Patients Treated With Norditropin®
NCT00960128 ·Status: COMPLETED
-
Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
NCT01947907 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq
NCT00234533 ·Status: COMPLETED ·Phase: PHASE3
-
Molecular Basis of the Growth Axis in Short Stature
NCT00453245 ·Status: COMPLETED